Advertisement
Screener

TENAX THERAPEUTICS, INC. (TENX) Stock-Based Compensation

2.8 / 5 stars · 68/120 Roast Me

TENAX THERAPEUTICS, INC. Stock-Based Compensation

TENAX THERAPEUTICS, INC. (TENX) reported Stock-Based Compensation of $6.17 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-31.

Financial Statements › Cash Flow › Operating Activities

us-gaap:ShareBasedCompensation · last filed 2026-07-31

  • TENAX THERAPEUTICS, INC. share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $3.33M, a 27.75% decline year-over-year.
  • TENAX THERAPEUTICS, INC. share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $2.84M, a 31.48% decline year-over-year.
  • TENAX THERAPEUTICS, INC. share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $4.79M, a 393.81% increase year-over-year.
  • TENAX THERAPEUTICS, INC. share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $5.62M, a 40057.14% increase year-over-year.
  • TENAX THERAPEUTICS, INC. share-based payment arrangement, noncash expense for fiscal 2025 was $19.16M, a 1603.38% increase from fiscal 2024.
  • TENAX THERAPEUTICS, INC. share-based payment arrangement, noncash expense for fiscal 2024 was $1.13M, a 489.01% increase from fiscal 2023.
  • TENAX THERAPEUTICS, INC. share-based payment arrangement, noncash expense for fiscal 2023 was $191.00K.
  • TENAX THERAPEUTICS, INC. share-based payment arrangement, noncash expense for fiscal 2019 was $0.00, a 100.00% decline from fiscal 2018.
Period endShare-based Payment Arrangement, Noncash Expense 3 monthShare-based Payment Arrangement, Noncash Expense 6 monthShare-based Payment Arrangement, Noncash Expense 8 monthShare-based Payment Arrangement, Noncash Expense 9 monthShare-based Payment Arrangement, Noncash Expense 12 monthShare-based Payment Arrangement, Noncash Expense 530 monthShare-based Payment Arrangement, Noncash Expense 533 monthShare-based Payment Arrangement, Noncash Expense 536 monthShare-based Payment Arrangement, Noncash Expense 539 monthShare-based Payment Arrangement, Noncash Expense 542 monthShare-based Payment Arrangement, Noncash Expense 545 monthShare-based Payment Arrangement, Noncash Expense 554 monthShare-based Payment Arrangement, Noncash Expense 557 month
2026-06-30$3.33M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-31
$6.17M
10-Q · filed 2026-07-31
$10.96M
derived: sum of 3 quarters · filed 2026-07-31
$16.58M
derived: sum of 4 quarters · filed 2026-07-31
2026-03-31$2.84M
10-Q · filed 2026-05-12
$7.63M
derived: sum of 2 quarters · filed 2026-05-12
$13.25M
derived: sum of 3 quarters · filed 2026-05-12
$17.86M
derived: sum of 4 quarters · filed 2026-07-31
2025-12-31$4.79M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10
$10.41M
derived: sum of 2 quarters · filed 2026-03-10
$15.02M
derived: sum of 3 quarters · filed 2026-07-31
$19.16M
10-K · filed 2026-03-10
2025-09-30$5.62M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12
$10.23M
derived: sum of 2 quarters · filed 2026-07-31
$14.37M
10-Q · filed 2025-11-12
$15.34M
derived: sum of 4 quarters · filed 2026-07-31
2025-06-30$4.61M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-31
$8.75M
10-Q · filed 2026-07-31
$9.72M
derived: sum of 3 quarters · filed 2026-07-31
$9.73M
derived: sum of 4 quarters · filed 2026-07-31
2025-03-31$4.14M
10-Q · filed 2026-05-12
$5.11M
derived: sum of 2 quarters · filed 2026-05-12
$5.13M
derived: sum of 3 quarters · filed 2026-05-12
$5.15M
derived: sum of 4 quarters · filed 2026-05-12
2024-12-31$970.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10
$984.00K
derived: sum of 2 quarters · filed 2026-03-10
$1.01M
derived: sum of 3 quarters · filed 2026-03-10
$1.13M
10-K · filed 2026-03-10
2024-09-30$14.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12
$36.00K
derived: sum of 2 quarters · filed 2025-11-12
$155.00K
10-Q · filed 2025-11-12
2024-06-30$22.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13
$141.00K
10-Q · filed 2025-08-13
2024-03-31$119.00K
10-Q · filed 2025-05-14
2023-12-31$191.00K
10-K · filed 2025-03-25
2019-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30
$0.00
derived: sum of 2 quarters · filed 2020-03-30
$0.00
derived: sum of 3 quarters · filed 2020-03-30
$0.00
10-K · filed 2020-03-30
2019-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14
$0.00
derived: sum of 2 quarters · filed 2019-11-14
$0.00
10-Q · filed 2019-11-14
$53.16K
derived: sum of 4 quarters · filed 2020-03-30
2019-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14
$0.00
10-Q · filed 2019-08-14
$53.16K
derived: sum of 3 quarters · filed 2020-03-30
-$73.78K
derived: sum of 4 quarters · filed 2020-03-30
2019-03-31$0.00
10-Q · filed 2019-05-15
$53.16K
derived: sum of 2 quarters · filed 2020-03-30
-$73.78K
derived: sum of 3 quarters · filed 2020-03-30
$51.23K
derived: sum of 4 quarters · filed 2020-03-30
2018-12-31$53.16K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30
-$73.78K
derived: sum of 2 quarters · filed 2020-03-30
$51.23K
derived: sum of 3 quarters · filed 2020-03-30
$190.08K
10-K · filed 2020-03-30
2018-09-30-$126.94K
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14
-$1.94K
derived: sum of 2 quarters · filed 2019-11-14
$136.92K
10-Q · filed 2019-11-14
$136.99K
derived: sum of 4 quarters · filed 2019-11-14
2018-06-30$125.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14
$263.86K
10-Q · filed 2019-08-14
$263.93K
derived: sum of 3 quarters · filed 2019-08-14
$263.93K
derived: sum of 4 quarters · filed 2019-08-14
2018-03-31$138.86K
10-Q · filed 2019-05-15
$138.92K
derived: sum of 2 quarters · filed 2019-05-15
$138.92K
derived: sum of 3 quarters · filed 2019-05-15
$138.99K
derived: sum of 4 quarters · filed 2019-05-15
2017-12-31$64.00
derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01
$64.00
derived: sum of 2 quarters · filed 2019-04-01
$131.00
derived: sum of 3 quarters · filed 2019-04-01
$79.59K
10-K · filed 2019-04-01
2017-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14
$67.00
derived: sum of 2 quarters · filed 2018-11-14
$79.53K
10-Q · filed 2018-11-14
$79.73K
derived: sum of 4 quarters · filed 2018-11-14
2017-06-30$67.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-14
$79.53K
10-Q · filed 2018-08-14
$79.73K
derived: sum of 3 quarters · filed 2018-08-14
$80.01K
derived: sum of 4 quarters · filed 2018-08-14
2017-03-31$79.46K
10-Q · filed 2018-05-15
$79.66K
derived: sum of 2 quarters · filed 2018-05-15
$79.95K
derived: sum of 3 quarters · filed 2018-05-15
$80.21K
derived: sum of 4 quarters · filed 2018-05-15
2016-12-31$204.00
derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02
$489.00
derived: sum of 2 quarters · filed 2018-04-02
$749.00
derived: sum of 3 quarters · filed 2018-04-02
$1.06K
10-K · filed 2018-04-02
2016-09-30$285.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09
$545.00
derived: sum of 2 quarters · filed 2017-11-09
$858.00
10-Q · filed 2017-11-09
2016-06-30$260.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09
$573.00
10-Q · filed 2017-08-09
2016-03-31$313.00
10-Q · filed 2017-05-10
2015-12-31$703.00
10-K · filed 2017-03-16
2015-10-31$304.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-12-10
$572.00
10-Q · filed 2015-12-10
2015-09-30$268.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09
$1.19K
10-Q · filed 2016-11-09
2015-07-31$268.00
10-Q · filed 2015-09-09
2015-06-30$467.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09
$921.00
10-Q · filed 2016-08-09
2015-04-30$42.13K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16
$117.30K
10-K · filed 2017-03-16
2015-03-31$454.00
10-Q · filed 2016-05-10
2015-01-31$25.45K
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-03-17
$60.32K
derived: sum of 2 quarters · filed 2015-12-10
$75.16K
10-Q · filed 2015-03-17
$473.12K
derived: sum of 4 quarters · filed 2017-03-16
2014-10-31$34.87K
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-12-10
$49.71K
10-Q · filed 2015-12-10
$447.67K
derived: sum of 3 quarters · filed 2017-03-16
$620.99K
derived: sum of 4 quarters · filed 2017-03-16
2014-07-31$14.84K
10-Q · filed 2015-09-09
$412.80K
derived: sum of 2 quarters · filed 2017-03-16
$586.12K
derived: sum of 3 quarters · filed 2017-03-16
$653.04K
derived: sum of 4 quarters · filed 2017-03-16
2014-04-30$397.96K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16
$571.28K
derived: sum of 2 quarters · filed 2017-03-16
$638.20K
derived: sum of 3 quarters · filed 2017-03-16
$651.46K
10-K · filed 2017-03-16
2014-01-31$173.32K
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-03-17
$240.24K
derived: sum of 2 quarters · filed 2015-03-17
$253.50K
10-Q · filed 2015-03-17
$269.47K
derived: sum of 4 quarters · filed 2016-03-14
$1.12M
10-Q · filed 2014-03-17
2013-10-31$66.92K
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-12-15
$80.18K
10-Q · filed 2014-12-15
$96.15K
derived: sum of 3 quarters · filed 2016-03-14
$119.40K
derived: sum of 4 quarters · filed 2016-03-14
$947.97K
10-Q · filed 2013-12-17
2013-07-31$13.26K
10-Q · filed 2014-09-15
$29.23K
derived: sum of 2 quarters · filed 2016-03-14
$52.49K
derived: sum of 3 quarters · filed 2016-03-14
$123.12K
derived: sum of 4 quarters · filed 2016-03-14
$881.05K
10-Q · filed 2013-09-17
2013-04-30$15.97K
derived: 10-KT 12 month − 10-Q 9 month · filed 2016-03-14
$39.23K
derived: sum of 2 quarters · filed 2016-03-14
$109.86K
derived: sum of 3 quarters · filed 2016-03-14
$185.26K
10-KT · filed 2016-03-14
$867.79K
10-K · filed 2013-06-26
2013-01-31$23.26K
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-03-17
$93.89K
derived: sum of 2 quarters · filed 2014-03-17
$169.29K
10-Q · filed 2014-03-17
$190.63K
derived: sum of 4 quarters · filed 2014-03-17
$851.82K
10-Q · filed 2013-03-18
2012-10-31$70.63K
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-12-17
$146.04K
10-Q · filed 2013-12-17
$167.37K
derived: sum of 3 quarters · filed 2013-12-17
$222.22K
derived: sum of 4 quarters · filed 2013-12-17
$828.56K
10-Q · filed 2012-12-14
2012-07-31$75.41K
10-Q · filed 2013-09-17
$96.74K
derived: sum of 2 quarters · filed 2013-09-17
$151.59K
derived: sum of 3 quarters · filed 2013-09-17
$177.69K
derived: sum of 4 quarters · filed 2013-09-17
$757.93K
10-Q · filed 2012-09-19
2012-04-30$21.34K
derived: 10-K 12 month − 10-Q 9 month · filed 2013-06-26
$76.19K
derived: sum of 2 quarters · filed 2013-06-26
$102.29K
derived: sum of 3 quarters · filed 2013-06-26
$127.53K
10-K · filed 2013-06-26
$682.53K
10-K · filed 2012-07-25
2012-01-31$54.85K
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-03-18
$80.95K
derived: sum of 2 quarters · filed 2013-03-18
$106.19K
10-Q · filed 2013-03-18
$109.28K
derived: sum of 4 quarters · filed 2013-03-18
$661.19K
10-Q · filed 2012-03-15
2011-10-31$26.10K
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-12-14
$51.34K
10-Q · filed 2012-12-14
$54.43K
derived: sum of 3 quarters · filed 2012-12-14
$57.50K
derived: sum of 4 quarters · filed 2012-12-14
$606.34K
10-Q · filed 2011-12-15
2011-07-31$25.24K
10-Q · filed 2012-09-19
$28.33K
derived: sum of 2 quarters · filed 2012-09-19
$31.39K
derived: sum of 3 quarters · filed 2012-09-19
$35.85K
derived: sum of 4 quarters · filed 2012-09-19
$580.24K
10-Q · filed 2011-09-19
2011-04-30$3.09K
derived: 10-K 12 month − 10-Q 9 month · filed 2012-07-25
$6.16K
derived: sum of 2 quarters · filed 2012-07-25
$10.61K
derived: sum of 3 quarters · filed 2012-07-25
$59.41K
10-K · filed 2012-07-25
2011-01-31$3.07K
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-03-15
$7.52K
derived: sum of 2 quarters · filed 2012-03-15
$56.32K
10-Q · filed 2012-03-15
2010-10-31$4.46K
derived: 10-Q 6 month − 10-Q 3 month · filed 2011-12-15
$53.25K
10-Q · filed 2011-12-15
2010-07-31$48.80K
10-Q · filed 2011-09-19

Similar stocks

Stock NameCountryMarket CapPE Ratio
PLIANT THERAPEUTICS, INC. (PLRX)United States$0.071B-0.76
PMV Pharmaceuticals, Inc. (PMVP)United States$0.071B-0.95
Yarrow Bioscience, Inc. (YARW)United States$0.070B
Lunai Bioworks Inc. (LNAI)United States$0.072B-0.11
Spero Therapeutics, Inc. (SPRO)United States$0.073B17.41
Connect Biopharma Holdings Ltd (CNTB)$0.069B-2.17
Cingulate Inc. (CING)United States$0.073B-2.64
Aldeyra Therapeutics, Inc. (ALDX)United States$0.074B-5.57
XBiotech Inc. (XBIT)United States$0.066B-1.56
OS Therapies Inc (OSTX)United States$0.076B-2.17